Skip to main content
STAR IMAGING AND PATH LAB LIMITED logo

STAR IMAGING AND PATH LAB LIMITED — Investor Relations & Filings

Ticker · 544482 ISIN · INE0YG001013 LEI · 335800TKEZHNKS6NL575 BSE.NS Human health and social work activities
Open in API
Filings indexed 8 across all filing types
Latest filing 2026-05-25 Report Publication Anno…
Country IN India
Listing BSE.NS 544482

About STAR IMAGING AND PATH LAB LIMITED

https://www.starimaging.in/

Star Imaging and Path Lab Limited is a diagnostic service provider specializing in comprehensive radiology and pathology services. The company offers a wide range of diagnostic modalities, including high-resolution MRI, multi-slice CT scans, digital X-rays, ultrasound, and mammography. Its pathology division provides extensive clinical testing, ranging from routine blood work to specialized molecular diagnostics and histopathology. The organization is recognized for utilizing advanced medical imaging technology and maintaining quality standards through NABL and NABH accreditations. Key services include preventive health packages, home sample collection, and tele-radiology. The company serves individual patients, healthcare institutions, and corporate entities, focusing on diagnostic accuracy, rapid turnaround times, and patient-centric care through its network of diagnostic centers.

Recent filings

Filing Released Lang Actions
Intimation of the audio recording of Analysts / Institutional Investors / Organisations meet-Earnings Call
Report Publication Announcement Classification · 72% confidence The document is a formal disclosure under SEBI LODR Regulation 30(6) notifying the stock exchange that the audio recording of the company’s earnings call has been published on the corporate website. It does not contain any financial results itself, nor is it a transcript, but rather an announcement that a related company report (the earnings call recording) has been released. This fits the definition of a Report Publication Announcement (RPA).
2026-05-25 English
Investor Presentation for Half and Financial Year ended 31st March 2026
Investor Presentation Classification · 95% confidence The document is a slide deck titled “Investor Presentation FY26 Earnings Update” attached to a stock exchange disclosure under SEBI Regulation 30(6). It contains management commentary, financial highlights, charts and strategic information targeted at investors, consistent with an Investor Presentation rather than a formal earnings release, annual report, or interim report. Therefore, it should be classified as an Investor Presentation (IP).
2026-05-25 English
Approved the Audited (Standalone and Consolidated ) Financial Statement for the Half and Year ended 31st March 2026
Audit Report / Information Classification · 85% confidence The document is a formal SEBI LODR disclosure by the company’s Board announcing and enclosing its audited standalone and consolidated financial results for the half year and full year ended March 31, 2026. It contains the auditor’s report (unmodified opinion) and detailed notes on accounting policies, IPO proceeds utilization, segment reporting, etc. This is not a full Annual Report (10-K) or mere earnings highlights (ER): it is the standalone audit report on periodic financial results. Therefore it best matches the “Audit Report / Information (AR)” category.
2026-05-22 English
Approved the Audited (Standalone and consolidated) financial results of the Company for the Half and Financial year ended 31 March 2026
Interim / Quarterly Report Classification · 90% confidence The document is a formal SEBI LODR announcement to the stock exchange by the company’s listing compliance department. It reports the Board’s approval of audited standalone and consolidated financial results for the half-year and full financial year ended March 31, 2026, and includes the detailed financial results, auditor’s report, and notes. It is not merely an earnings release (key highlights) nor just a publication notice, and it is not a full annual report. It fits the definition of an Interim/Quarterly Report (half-year audited results with substantive financial data under Regulation 33). FY 2026
2026-05-22 English
Intimation under Regulation 30(6) of SEBI (Listing Obligations and Disclosure Requirements), Regulations, 2015- Investor meet for the Half Year and Financial Year Ended March 31,2026
Regulatory Filings Classification · 85% confidence The document is a listing compliance intimation under SEBI LODR Reg.30(6) notifying an investor meet/earnings conference call for the half year and financial year ended March 31, 2026. It does not contain actual financial results or substantive performance data; rather it is an announcement of a meeting/call. It does not fit into earnings release (ER), interim report (IR), or investor presentation (IP) since no presentation or financial statements are included. Therefore it is a general regulatory filing under the Listing Obligations and Disclosure Requirements (fallback category).
2026-05-19 English
Star Imaging And Path Lab Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 22/05/2026 ,inter alia, to consider and approve Audited (Standalone ....
Regulatory Filings Classification · 10% confidence The document is a stock exchange compliance notice under SEBI Listing Obligations (Regulation 29) informing of a Board meeting date to consider audited financial results. It does not contain the financial results themselves or any substantive financial statements, nor is it a proxy material or director change. This is an announcement of a regulatory compliance event, so it falls into the general Regulatory Filings (RNS) category.
2026-05-15 English

Browse filings by year

1 year

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.